Faculty Profile

Molly  Nozyce, PhDMolly Nozyce, PhD
Phone: 718-918-4076
E-mail: molly.nozyce@nychhc.org

Dr. Nozyce is the Director of the Division of Developmental Pediatrics. Dr Nozyce is an Associate Professor of Pediatrics at the Albert Einstein College of Medicine.

Undergraduate School:

Hunter College

Graduate School:

New School for Social Research
Yeshiva University, Ferkauf Graduate School of Psychology, PhD


  • Internship: Albert Einstein College of Medicine
  • Developmental-Behavioral Fellowship: Bronx Developmental Center


  • Grant R, Nozyce M. Proposed changes to the American Psychiatric Association diagnostic criteria for autism spectrum disorder: implications for young children and their families. Matern Child Health J. 2013 May;17(4):586-92.
  • Sirois PA, Huo Y, Nozyce ML; Pediatric HIVAIDS Cohort Study. Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants. Pediatr Infect Dis J. 2013 Jun;32(6):648-55.
  • Miller TI, Borkowsky W, Nozyce M, et al. Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children. HIV Med. 2012 May;13(5):264-75.
  • Kapetanovic S, Aaron L, Nozyce ML, et al; Pediatric AIDS Clinical Trials. The use of second-generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV. AIDS Patient Care STDS. 2009 Nov;23(11):939-47.
  • Sirois PA, Montepiedra G, Nozyce ML; IMPAACT/PACTG 219C Team. Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV. J Dev Behav Pediatr. 2009 Oct;30(5):403-12.
  • Nozyce ML, Lee SS, Wiznia A, et al: A behavioral and cognitive profile of clinically stable HIV-infected children. Pediatrics 2006;117:763-70.
  • Jeremy RJ, Kim S, Nozyce M, et al: Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children. Pediatrics 2005;115:380-7.
  • Pearson DA, McGrath NM, Nozyce M, et al: Predicting HIV disease progression in children using measures of neuropsychological and neurological functioning. Pediatrics 2000;106:E76.
  • Raskino C, Pearson DA, Baker CJ, Lifschitz MH, O'Donnell K, Mintz M, Nozyce M, et al: Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatrics 1999;104:e32.